BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20514076)

  • 1. β-Arrestin2 influences the response to methadone in opioid-dependent patients.
    Oneda B; Crettol S; Bochud M; Besson J; Croquette-Krokar M; Hämmig R; Monnat M; Preisig M; Eap CB
    Pharmacogenomics J; 2011 Aug; 11(4):258-66. PubMed ID: 20514076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between β-arrestin2 genetic polymorphism and response to methadone maintenance treatment in heroin-dependent patients in Han population in Hunan province].
    Luo R; Feng XL; Luo X; Liu ZS; Hu PW; Liu S; Li XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):872-5. PubMed ID: 27346119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.
    Ambrose-Lanci LM; Vaswani M; Clarke TK; Zeng A; Lohoff FW; Ferraro TN; Berrettini WH
    Psychiatr Genet; 2012 Jun; 22(3):141-5. PubMed ID: 22472784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.
    de Cid R; Fonseca F; Gratacòs M; Gutierrez F; Martín-Santos R; Estivill X; Torrens M
    Genes Brain Behav; 2008 Jul; 7(5):515-22. PubMed ID: 18182069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia.
    Ikeda M; Ozaki N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Kishi T; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Inada T; Iwata N
    Genes Brain Behav; 2007 Feb; 6(1):107-12. PubMed ID: 17233643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
    Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.
    Luo R; Li X; Qin S; Luo Z; Luo X; Hu P; Liu Z; Feng X; Li X
    Pharmacogenomics; 2017 Dec; 18(18):1659-1670. PubMed ID: 29173032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in
    Ozberk D; Haywood A; Sutherland HG; Yu C; Albury CL; Zunk M; George R; Good P; Griffiths LR; Hardy J; Haupt LM
    Pharmacogenomics; 2022 Apr; 23(5):281-289. PubMed ID: 35189719
    [No Abstract]   [Full Text] [Related]  

  • 9. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers.
    Sun D; Ma JZ; Payne TJ; Li MD
    Mol Psychiatry; 2008 Apr; 13(4):398-406. PubMed ID: 17579607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.
    Ferrer-Alcón M; La Harpe R; García-Sevilla JA
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):114-22. PubMed ID: 14969742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
    Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.
    Sankey C; Setnik B; Harsanyi Z; Michalko K; Yang Z; Geoffroy P
    J Opioid Manag; 2016; 12(2):149-59. PubMed ID: 27194200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK; Barratt DT; Dahlen K; Loennechen MH; Somogyi AA
    Clin Pharmacol Ther; 2006 Dec; 80(6):682-90. PubMed ID: 17178268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
    Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.